HLA class II analysis in Jewish Israeli narcoleptic patients.
HLA class II was investigated in eight Jewish narcoleptic patients, representing the total of such patients known in Israel at present, and in three patients suffering from sleep disturbances other than narcolepsy. All (11 out of 11) patients carried the serologic specificities DR2, DQ6 (DQ1). At the DNA level, all narcoleptics were found to be DRB1*1501, DQA1*0102, DQB1*0602 which indicates that the susceptibility gene may be located within the HLA class II region, DR, and/or DQ. As for the nonnarcoleptic patients with idiopathic hypersomnia, they carried different alleles of DR2 and DQ6, namely DRB1*1502, DQA1*0103, DQB1*0601. This study confirms that the incidence of narcolepsy in Israel is extremely low and that HLA class II genes or a gene(s) tightly linked to them are involved in the disease.
Kwon
O J
OJ
Tissue Typing Unit, Hebrew University-Hadassah Medical Organization, Jerusalem, Israel.
Peled
N
N
Miller
K
K
Pillar
G
G
Peled
R
R
Lavie
P
P
Brautbar
C
C
Amar
A
A
D000483:Alleles; D016022:Case-Control Studies; D006970:Disorders of Excessive Somnolence / Q000235:genetics / Q000276:immunology; D005787:Gene Frequency; D008040:Genetic Linkage; D006681:HLA-D Antigens / Q000235:genetics*; D006683:HLA-DQ Antigens / Q000235:genetics; D015802:HLA-DR2 Antigen / Q000235:genetics; D006801:Humans; D007557:Israel; D007585:Jews / Q000235:genetics; D009290:Narcolepsy / Q000175:diagnosis / Q000235:genetics* / Q000276:immunology*
D006681:HLA-D Antigens; D006683:HLA-DQ Antigens; C063831:HLA-DQ6 antigen; D015802:HLA-DR2 Antigen